US OptionsDetailed Quotes

BCRX241220C3000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 4 09:30 ET

0.00High0.00Low

BioCryst Pharmaceuticals Stock Discussion

Jaguar8

Nov 7 09:30

13G

$BioCryst Pharmaceuticals (BCRX.US)$
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.81%)

frogoracletrading

Nov 4 06:06

$BCRX Support / Resistance Levels

Here are the levels to watch this week.
Larger Image: tradingview.com...
$BioCryst Pharmaceuticals (BCRX.US)$

Trytosaveabit

Oct 14 06:13

Update

$BioCryst Pharmaceuticals (BCRX.US)$ BioCryst's ORLADEYO Reduces Hospital Visits and Emergency Care for Hereditary Angioedema Patients, Study Shows
Benzinga· 3 mins ago
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO (berotralstat) demonstrating that patients with hereditary angioedema (HAE) in the United States experience significant reductions in healthcare resource utilization (HRU), including significant reduc...

Trytosaveabit

Sep 30 06:02

News

$BioCryst Pharmaceuticals (BCRX.US)$ Reuters
Just
U.S. Government Awards BioCryst $69 Million Rapivab® (Peramivir Injection) Contract for Strategic National Stockpile

Analysts Notebook

Sep 5 06:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

Trytosaveabit

Jul 9 06:04

Update

$BioCryst Pharmaceuticals (BCRX.US)$ Reuters · 1 min ago BioCryst Pharmaceuticals- Orladeyo® (Berotralstat) Approved in Peru

Trytosaveabit

May 29 16:07

Insider buy

$BioCryst Pharmaceuticals (BCRX.US)$ Director ASELAGE STEVE purchased 2,500 shares of common stock on May 24, 2024 at an average price of $6.4 for a total value of $16,000.

Trytosaveabit

May 15 09:25

$BioCryst Pharmaceuticals (BCRX.US)$

Trytosaveabit

May 9 06:43

Update

$BioCryst Pharmaceuticals (BCRX.US)$ Benzinga· 1 min BioCryst Presents New Real-world Evidence Showing Significant Reductions In Healthcare Resource Utilization Among Patients With Hereditary Angioedema Following Initiation Of Orladeyo (Berotralstat

Trytosaveabit

May 6 06:14

Not bad

$BioCryst Pharmaceuticals (BCRX.US)$ BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
—Q1 2024 ORLADEYO net revenue grows 30 percent y-o-y to $88.9 million—
—Full-year 2024 ORLADEYO revenue guidance adjusted to $390-$400 million (top end of prior guidance range) —
—Pipeline programs, including BCX17725 for Netherton syndrome and avoralstat for DME, advancing on schedule into clinical trials—

No comment yet